NCT00519857View on ClinicalTrials.gov

Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)

PHASE3CompletedINTERVENTIONAL
Enrollment

4,534

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Osteoporosis
Interventions
DRUG

Tibolone

1.25 mg p.o, once daily for 3 years

DRUG

Placebo

Tablet p.o, once daily for 3 years

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00519857 - Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) | Biotech Hunter | Biotech Hunter